These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35859842)

  • 61. Evidence in Asian Food Industry: Intellectual Capital, Corporate Financial Performance, and Corporate Social Responsibility.
    Tsai CH; Mutuc EB
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31968553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Perception of Corporate Hypocrisy in China: The Roles of Corporate Social Responsibility Implementation and Communication.
    Zhao Y; Qin Y; Zhao X; Wang X; Shi L
    Front Psychol; 2020; 11():595. PubMed ID: 32425840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How does anti-corruption affect enterprise green innovation in China's energy-intensive industries?
    Chen X; Chen G; Lin M; Tang K; Ye B
    Environ Geochem Health; 2022 Sep; 44(9):2919-2942. PubMed ID: 34762254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Corporate social responsibilities, sustainable investment, and the future of green bond market: evidence from renewable energy projects in Morocco.
    Ahmad S; Mokhchy J
    Environ Sci Pollut Res Int; 2023 Feb; 30(6):15186-15197. PubMed ID: 36166123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nexus between corporate social responsibility and firm's perceived performance: evidence from SME sector of developing economies.
    Yumei H; Iqbal W; Nurunnabi M; Abbas M; Jingde W; Chaudhry IS
    Environ Sci Pollut Res Int; 2021 Jan; 28(2):2132-2145. PubMed ID: 32875447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hometown attachment and corporate social responsibility: Evidence from overseas Chinese entrepreneurs.
    Xia J; Wu Z; Dang Z; Zhang R
    Front Psychol; 2022; 13():943701. PubMed ID: 36211914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies.
    Chai KC; Tao R; Chang KC; Yang Y
    Front Public Health; 2020; 8():93. PubMed ID: 32322567
    [No Abstract]   [Full Text] [Related]  

  • 68. Strategic orientation, business model innovation and corporate performance-Evidence from construction industry.
    Han W; Zhou Y; Lu R
    Front Psychol; 2022; 13():971654. PubMed ID: 36337575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CEO birth order and corporate social responsibility behaviors: The moderating effect of female sibling and age gap.
    Zheng M; Ren G; Wu S; Jiang Z
    Front Psychol; 2022; 13():1003704. PubMed ID: 36405214
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Corporate social responsibility: a real options approach to the challenge of financial sustainability.
    Bosch-Badia MT; Montllor-Serrats J; Tarrazon-Rodon MA
    PLoS One; 2015; 10(5):e0125972. PubMed ID: 25938410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Research on the innovation incentive effect and heterogeneity of the market-incentive environmental regulation on mineral resource enterprises.
    Wei Y; Xu D; Zhang K; Cheng J
    Environ Sci Pollut Res Int; 2021 Nov; 28(41):58456-58469. PubMed ID: 34115294
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Do the Green Credit Guidelines Affect Corporate Green Technology Innovation? Empirical Research from China.
    Hong M; Li Z; Drakeford B
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33578645
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Environmental information disclosure, political connections and innovation in high-polluting enterprises.
    Cailou J; Fuyu Z; Chong W
    Sci Total Environ; 2021 Apr; 764():144248. PubMed ID: 33385643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Corporate Environmental Performance in China: The Moderating Effects of the Media versus the Approach of Local Governments.
    Guo Z; Lu C
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379266
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Corporate Social Responsibility Framework: An Innovative Solution to Social Determinants of Health in the USA.
    Jain P; Jain B; Dee EC
    J Racial Ethn Health Disparities; 2024 Feb; 11(1):7-22. PubMed ID: 36689122
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Corporate social responsibility, debt financing cost and enterprise innovation.
    Yao JJ; Qi YA; Guo B
    Sci Rep; 2022 Dec; 12(1):21909. PubMed ID: 36535966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Environmental cooperation system, ESG performance and corporate green innovation: Empirical evidence from China.
    Qiang S; Gang C; Dawei H
    Front Psychol; 2023; 14():1096419. PubMed ID: 36935950
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Threshold effects of energy consumption, technological innovation, and supply chain management on enterprise performance in China's manufacturing industry.
    Liu H; Fan L; Shao Z
    J Environ Manage; 2021 Dec; 300():113687. PubMed ID: 34530370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.